2-naphthol has been researched along with imatinib mesylate in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abe, R; Hara, Y; Horikawa, K; Murata, T; Obata, Y; Shiina, I; Suzuki, K; Tasaki, Y | 1 |
1 other study(ies) available for 2-naphthol and imatinib mesylate
Article | Year |
---|---|
M-COPA suppresses endolysosomal Kit-Akt oncogenic signalling through inhibiting the secretory pathway in neoplastic mast cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Proliferation; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Endosomes; Enzyme Activation; Humans; Imatinib Mesylate; Lysosomes; Mast Cells; Mice; Naphthols; Phosphorylation; Protein Processing, Post-Translational; Protein Transport; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-kit; Pyridines; Secretory Pathway; Signal Transduction | 2017 |